Sheba kicks off groundbreaking trial of fourth COVID vaccine dose

Sheba Medical Center, outside Tel Aviv, has begun trials of a fourth dose of coronavirus vaccine in what is believed to be the first study of its kind.

The trial begins with 150 medical personnel who received a booster dose in August getting a fourth shot of the Pfizer-BioNTech vaccine. The staff receiving the additional dose were tested and found to have low antibody levels.

Professor Jacob Lavee receives a fourth dose of Pfizer-BioNTech COVID-19 vaccine, at Sheba Medical Center in Ramat Gan, Israel, Monday, Dec. 27, 2021. (AP/Tsafrir Abayov)

The trial comes after Israeli officials considered rolling out a second tranche of booster shots to its population as the country grapples with rising infections due to the new Omicron variant.

Prof. Jacob Lavee, former director of the heart transplant unit at Sheba, says “hopefully, we’ll be able to show here… that this fourth booster really provides protection against Omicron, which is highly needed.”

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.